APA (7th ed.) Citation

B, B., P, H., O, G., J, S., OR, G., B, I., . . . LL, R. (2020). The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors. The Journal of clinical investigation, 130(3), 1330. https://doi.org/10.1172/JCI129697

Chicago Style (17th ed.) Citation

B, Balbino, et al. "The Anti-IgE MAb Omalizumab Induces Adverse Reactions by Engaging Fcγ Receptors." The Journal of Clinical Investigation 130, no. 3 (2020): 1330. https://doi.org/10.1172/JCI129697.

MLA (9th ed.) Citation

B, Balbino, et al. "The Anti-IgE MAb Omalizumab Induces Adverse Reactions by Engaging Fcγ Receptors." The Journal of Clinical Investigation, vol. 130, no. 3, 2020, p. 1330, https://doi.org/10.1172/JCI129697.